Episode Synopsis "Intro to Pathology and Molecular Pathology, with Dr. Dara Aisner, Part 3: A Glimpse into the Future (audio)"

Dr. Dara Aisner, Pathologist at the University of Colorado, describes emerging technological changes that will advance how molecular marker testing is done, to make it faster and more complete over time.

Listen "Intro to Pathology and Molecular Pathology, with Dr. Dara Aisner, Part 3: A Glimpse into the Future (audio)"

More episodes of the podcast GRACEcast Cancer 101 Audio

• Dr. Suresh Ramalingam: Question and Answer Session on Clinical Trials in Oncology (audio)
• Dr. Suresh Ramalingam: Myths, Facts, and Patient Rights in Clinical Trials (audio)
• Dr. Suresh Ramalingam: How Are Clinical Trials Developed and Initiated? (audio)
• Dr. Suresh Ramalingam: What is a Clinical Trial? (audio)
• Intro to Pathology and Molecular Pathology, with Dr. Dara Aisner, Part 3: A Glimpse into the Future (audio)
• Intro to Pathology and Molecular Pathology, with Dr. Dara Aisner, Part 2: Practical Challenges in Testing (audio)
• Intro to Pathology and Molecular Pathology, with Dr. Dara Aisner, Part 1: What Do the Terms Mean? (audio)
• GRACEcast Feeds Moving (audio)
• Interview with Dr. Kristin Manning, Part 2: Challenges in Cancer Imaging (audio)
• Interview with Dr. David Djang; The Role of PET Scans in Oncology (audio)